secwatch.observer — SEC 8-K summary
======================================

Issuer:     VBI Vaccines Inc/BC (—)
CIK:        0000764195
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0001493152-24-029537
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 2.03, 2.04, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VBI Vaccines files for CCAA creditor protection; DIP loan of $2.5M at 17.5%
---------------------------------------------------------------------------

- Ontario Superior Court granted CCAA protection on July 29, 2024; Ernst & Young appointed monitor.
- K2 HealthVentures provides up to $2.5M DIP facility at 17.5% interest to fund operations during proceedings.
- VBI will seek Chapter 15 in US and Israeli insolvency protection; SISP for asset sale expected.
- Company notified Nasdaq of expected delisting and cessation of public reporting.
- Restructuring triggers default under existing Loan Agreement; obligations accelerated with 5% default interest increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/764195/000149315224029537/0001493152-24-029537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/764195/000149315224029537/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer